Journal
TRENDS IN PARASITOLOGY
Volume 21, Issue 11, Pages 494-498Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.pt.2005.08.020
Keywords
-
Categories
Funding
- Wellcome Trust [073896] Funding Source: Medline
Ask authors/readers for more resources
In the past 21 years, a modest increase in the range of antimalarial drugs approved for clinical use has been complemented by a more impressive expansion in the analysis and understanding of the molecular mechanisms underlying resistance to these agents. Such resistance is a major factor in the increasing difficulty in controlling malaria, and important developments during this period are recounted here.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available